Jaundice Treatment Guidelines Reaffirmed
More like this
- How Plans Can Improve Outcomes And Cut Costs for Preterm Infant Care
- Is Selective Use of Palivizumab Appropriate in Premature Infants?
- A Health Care Management Company's Experience with Palivizumab
- Despite Challenges, New Treatments Abound for AAT Deficiency
- Decreasing Medical Costs: How Insurers Are Taking the Easy Way Out